Tags : Prefilled Syringe

ViewPoints Interview: Genentech’s Ted Omachi Shares Insights on Xolair (omalizumab)

The US FDA has accepted the sBLA for a new self-administration option for Xolair (omalizumab) across all approved US indications. In an interview with PharmaShots, Ted Omachi the Global Development Leader for Xolair and Senior Medical Director of Product Development Immunology shares details and highlights of Xolair (omalizumab) PFS for self-administration. Shots: A decision on […]Read More

Roche Reports the US FDA’s Acceptance of sBLA for Xolair

Shots: The US FDA has accepted the sBLA for a new self-administration option for Xolair across all approved indications in the US. The company anticipates the approval of the therapy in Q1’21 The acceptance is based on the efficacy and safety profile of Xolair in allergic asthma and chronic idiopathic urticaria (CIA) If approved, Xolair’s […]Read More

B. Braun Launches its Heparin Sodium Prefilled Syringe in the

Shots: Heparin Sodium Injection, USP is the first Heparin 5,000 USP unit / 0.5 mL prefilled syringe attached with safety needle for subcutaneous and intravenous use The prefilled syringe is equipped with a label-integrated Schreiner MediPharm Needle-Trap system for the prevention of accidental needle stick injuries. The syringe is a preservative free with 24mos. stability […]Read More